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Background: Geriatric nutritional risk index (GNRI) is a validated nutritional assessment method, and lower GNRI 
values are closely associated with adverse clinical outcomes in dialysis patients. This study investigated the impact 
of changes in GNRI during the first year of dialysis on cardiovascular outcomes in incident peritoneal dialysis (PD) 
patients.
Methods: We reviewed medical records in 133 incident PD patients to determine GNRI at the start of PD and after 12 
months. Patients were categorized into improved (delta GNRI > 0) and worsening/stationary (delta GNRI ≤ 0) groups. 
The primary outcome was major adverse cardiac and cerebrovascular events (MACCEs).
Results: During a mean follow-up of 51.1 months, the primary outcome was observed in 42 patients (31.6%). The 
baseline GNRI at PD initiation was not significantly associated with MACCEs (log-rank test, P = 0.40). However, the 
cumulative event-free rate was significantly lower in the worsening or stationary GNRI group than in the improved 
group (log-rank test, P = 0.004). Multivariate Cox analysis revealed that a worsening or stationary GNRI was 
independently associated with higher risk for MACCEs (hazard ratio, 2.47; 95% confidence interval, 1.15-5.29; P = 
0.02). In subgroup analysis, patients with worsening or stationary GNRI were at significantly greater risk for MACCEs 
in both the lower (P = 0.04) and higher (P = 0.01) baseline GNRI groups.
Conclusion: Baseline GNRI was not associated with MACCEs, but patients with deteriorating or stationary nutritional 
status were at significantly greater risk for MACCEs, suggesting that serial monitoring of nutritional status is important 
to stratify cardiovascular risk in incident PD patients.
Keywords: Dialysis, Geriatric nutritional risk index, Major adverse cardiac and cerebrovascular events, Peritoneal 
dialysis, Protein-energy wasting
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Introduction
Cardiovascular disease is the most common cause of 
death in patients with end-stage renal disease (ESRD) 
treated with dialysis [1]. In addition to traditional risk 
factors, protein-energy wasting is an established risk fac-
tor for cardiovascular disease in dialysis patients [2-4]. 
Furthermore, it is well known that protein-energy wast-
ing worsens quality of life and clinical outcomes in these 
patients [2-8]. Therefore, identification and risk stratifi-
cation of protein-energy wasting are clinically relevant to 
the management of dialysis patients.
To date, many nutritional assessment methods have 
been developed and investigated in patients with ESRD 
[9-15]. The geriatric nutritional risk index (GNRI), origi-
nally developed to examine the nutritional status of 
elderly hospitalized patients, consists of three objective 
nutritional variables: height, body weight, and serum 
albumin concentration [16]. Lower GNRI is a significant 
risk factor for nutrition-related morbidity and mortal-
ity in elderly hospitalized patients [16]. In patients with 
ESRD, GNRI is a useful nutritional indicator [13,17]. The 
prognostic value of GNRI has also been studied in pa-
tients on hemodialysis (HD) [18-23] and peritoneal di-
alysis (PD) [24]. In HD, GNRI is a significant predictor of 
all-cause mortality in Korean [19], Japanese [18,23], and 
Caucasian [21,25] populations. GNRI is also a significant 
predictor of cardiovascular mortality in Japanese patients 
on maintenance HD [22]. In Korean PD patients, Kang et 
al [24] demonstrated that GNRI was independently asso-
ciated with all-cause mortality.
However, there are limited data on the association be-
tween changes in GNRI and clinical outcomes [20]. Be-
cause nutritional status constantly changes, the prognos-
tic value of GNRI can also change over time. Moreover, 
changes in nutritional status might be more prominent 
in patients initiating dialysis than in patients on chronic 
dialysis. With this in mind, the current study investigates 
the impact of changes in GNRI during the first year of PD 
on cardiovascular outcomes in incident PD patients.
Methods
Patients
The medical records of all patients with ESRD over 18 
years of age who started PD at Yonsei University Health 
System or CHA Bundang Medical Center between Janu-
ary 2005 and December 2008 were initially reviewed for 
this study. Among 323 incident PD patients, patients 
were excluded if they had malignancy (n = 12), active in-
fection (n = 3), or decompensated liver disease (n = 3) or 
if they did not maintain PD during the first three months 
(n = 54). Since this study was designed to investigate the 
effects of changes in GNRI during the first year of PD, 45 
patients who discontinued PD within the first year were 
excluded. Twenty-seven patients died within the first year 
of PD, 10 patients changed dialysis modality to HD, and 8 
patients underwent kidney transplantation. In addition, 
73 patients who maintained PD over one year but did not 
have one-year follow-up data (including demograph-
ics and laboratory variables) were excluded. Finally, 133 
patients were analyzed in the present study. This study 
was carried out in accordance with the Declaration of 
Helsinki and approved by the Institutional Review Board 
of Yonsei University Health System Clinical Trial Center 
(IRB No. 4-2016-0932) and CHA Bundang Medical Center 
Clinical Trial Center (IRB No. 2016-11-017).
Demographics and biochemical data collection
Baseline demographics and biochemical data were col-
lected from medical record reviews and were recorded 
by a well-trained examiner at the time of PD initiation. 
Traditional cardiovascular risk factors of age, hyperten-
sion, diabetes mellitus, smoking history, and cardio-
vascular disease history were recorded. Cardiovascular 
disease was defined as a history of coronary artery dis-
ease, peripheral artery disease, congestive heart failure, 
or cerebrovascular accident. Coronary artery disease was 
defined as history of angioplasty, coronary artery bypass 
grafting, myocardial infarction, or angina. Peripheral ar-
tery disease was defined as history of claudication, isch-
emic limb loss and/or ulceration, or peripheral revas-
cularization procedure. A cerebrovascular accident was 
defined as history of transient ischemic attack, stroke, or 
carotid endarterectomy. 
Blood was drawn after a 12-hour overnight fast, and 
the following laboratory data were measured from blood 
samples: hemoglobin, blood urea nitrogen, creatinine, 
calcium, phosphorous, albumin, total cholesterol, low-
density lipoprotein cholesterol, high-density lipoprotein 
cholesterol, triglycerides, intact parathyroid hormone, 
and high-sensitivity C-reactive protein (hs-CRP) con-
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centrations. Residual kidney function and urine volume 
were determined through 24-hour urine collection. Kt/
Vurea was determined from the total loss of urea nitrogen 
in the spent dialysate using PD Adequest 2.0 for Windows 
software (Baxter Healthcare, Deerfield, IL, USA).
Assessment of the GNRI
The GNRI was calculated with an equation validated in 
dialysis patients [13,17-19,21-26]: GNRI = [1.489 × albu-
min (g/L)] + [(41.7 × (body weight/ideal body weight)]. 
Ideal body weight was calculated from the Lorentz equa-
tion [16,17,24]. If a patient’s body weight was above the 
ideal body weight, the ratio of body weight to ideal body 
weight was replaced with 1, in accordance with previous 
studies [16,17,24,26]. In our study, the dry body weight 
was used as body weight and was determined by the pa-
tient’s nephrologist in the context of hypotension, blood 
pressure, peripheral edema, or pulmonary edema on 
chest X-ray. To reflect the actual status of patients, usual 
overnight dialysate volumes or glucose concentrations 
were not altered for this study. After complete emptying 
of the PD dialysate, patients were weighed in light cloth-
ing, and their heights were measured while they were not 
wearing shoes.
Outcome measurement
Patients were regularly followed up at the PD clinic un-
til December 2015. All deaths and hospitalizations were 
recorded in a serious adverse events database. All events 
were carefully reviewed for this study. The primary out-
come was development of a major adverse cardiac and 
cerebrovascular event (MACCE), which was defined as 
death or hospitalization from acute coronary syndrome, 
stable angina requiring coronary revascularization by 
percutaneous coronary intervention or coronary artery 
bypass grafting, congestive heart failure, or cerebrovas-
cular accident. Loss to follow-up, kidney transplantation, 
and dialysis modality change to HD after the first year of 
PD were censored at the end of PD treatment.
Statistical analysis
Statistical analyses were performed with IBM SPSS Sta-
tistics for Windows version 20.0 (IBM Co., Armonk, NY, 
USA). Continuous variables were expressed as mean ± 
standard deviation or median (interquartile range [IQR]), 
and categorical variables were expressed as number 
(percentage). Baseline characteristics were compared 
with Student’s t test, Mann-Whitney U test, or chi-square 
test between patients who did and did not experience 
MACCE. In the first analysis, 133 patients were divided 
into two groups of higher baseline GNRI (≥ 96.7) and 
lower baseline GNRI (< 96.7), according to median base-
line GNRI value. The effect of baseline GNRI on MACCE 
risk was tested by Kaplan-Meier analysis and time-vary-
ing Cox regression analysis. In the second analysis, the 
change in GNRI (delta GNRI) was calculated by subtract-
ing the baseline GNRI from GNRI one year after PD ini-
tiation to determine the prognostic value of GNRI change 
over the first year. Patients were categorized into two 
groups according to changed GNRI value: improved (delta 
GNRI > 0) and worsening or stationary (delta GNRI ≤ 0) 
groups. Cumulative survival curves were generated by 
the Kaplan-Meier method, and between-group survival 
was compared by a log-rank test. The independent prog-
nostic value of worsening or stationary GNRI in deter-
mining MACCE risk was ascertained by Cox’s regression 
analysis. Furthermore, subgroup analysis was performed 
according to baseline GNRI group to explore whether the 
impact of changes in GNRI on MACCE risk was affected 




Patient baseline characteristics are shown in Table 
1. The mean age was 50.8 ± 11.9 years, and 69 patients 
(51.9%) were men. The mean GNRI was 96.2 ± 8.3 (me-
dian 96.7, IQR 92.0-101.2). During a mean follow-up du-
ration of 51.1 months, MACCEs were observed in 42 pa-
tients (31.6%). The mean age, proportion of patients with 
cardiovascular disease history, and hs-CRP level were 
significantly higher in patients who experienced MAC-
CEs than in those who did not. High-density lipoprotein 
cholesterol concentrations were significantly lower in 
patients who had MACCEs than in those who did not. 
Baseline GNRI values did not differ significantly between 
patients with and without MACCEs.
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No significant association between baseline GNRI and 
MACCEs
Patients were divided into two groups according to the 
median value of baseline GNRI, which was 96.7. In the 
lower baseline GNRI group (GNRI < 96.7, n = 63), MAC-
CEs were observed in 19 patients (30.2%). In the higher 
baseline GNRI group (GNRI ≥ 96.7, n = 70), MACCEs were 
observed in 23 patients (32.9%). Kaplan-Meier analy-
sis indicated that event-free survival rates did not differ 
between the two groups (log-rank test, P = 0.40) (Fig. 1). 
Univariate time-varying Cox regression analysis revealed 
that patients in the lower baseline GNRI group were not 
at greater risk for MACCEs (hazard ratio [HR]=1.31, 95% 
confidence interval [CI] = 0.70-2.43, P = 0.40) than those 
in the higher baseline GNRI group.
Table 1. Baseline characteristics of patients according to incidence of MACCE
Characteristic All (n = 133) Patients with MACCE (n = 42) Patients without MACCE (n = 91) P value
Age (yr) 50.8 ± 11.9 55.1 ± 10.5 48.7 ± 12.0 0.004
Sex, men 69 (51.9) 21 (50.0) 48 (52.7) 0.85
Diabetes mellitus 20 (15.0) 8 (19.0) 12 (13.2) 0.44
CVD* 18 (13.5) 10 (23.8) 8 (8.8) 0.03
Smoker 40 (30.1) 11 (26.2) 29 (31.9) 0.55
SBP (mmHg) 134.3 ± 21.1 136.2 ± 20.2 133.4 ± 21.5 0.48
Height (cm) 162.1 ± 8.1 160.8 ± 8.3 162.7 ± 8.0 0.21
Body weight (kg) 59.8 ± 10.2 60.3 ± 9.7 59.6 ± 10.4 0.70
Hemoglobin (g/L) 107 ± 15 108 ± 15 106 ± 12 0.40
BUN (mmol/L) 21.3 ± 6.7 20.1 ± 5.9 21.8 ± 7.0 0.19
Creatinine (μmol/L) 875 ± 327 831 ± 344 892 ± 344 0.30
Albumin (g/L) 37 ± 5 37 ± 4 37 ± 5 0.81
Glucose (mmol/L) 5.3 ± 1.9 5.7 ± 3.1 5.1 ± 0.9 0.12
Calcium (mmol/L) 2.2 ± 0.2 2.2 ± 0.2 2.2 ± 0.2 0.51
Phosphorus (mmol/L) 1.6 ± 0.4 1.6 ± 0.4 1.6 ± 0.4 0.63
iPTH (ng/L) 167.0 (76.0-325.9) 159.6 (71.8-284.5) 189.0 (80.0-356.0) 0.51
Total cholesterol (mmol/L) 4.7 ± 1.0 4.6 ± 0.9 4.7 ± 1.0 0.41
HDL-C (mmol/L) 1.2 ± 0.4 1.1 ± 0.3 1.3 ± 0.4 0.04
LDL-C (mmol/L) 2.7 ± 0.8 2.7 ± 0.7 2.8 ± 0.9 0.41
Triglycerides (mmol/L) 1.6 ± 1.1 1.7 ± 1.3 1.5 ± 1.0 0.28
hs-CRP (mg/L) 1.2 (0.7-2.1) 1.5 (0.9-2.8) 1.0 (0.7-2.1) 0.04
Medications  
   RAS blockers 125 (94.0) 40 (95.2) 85 (93.4) 0.9
   Beta-blockers 91 (68.4) 26 (61.9) 65 (71.4) 0.32
   Calcium channel blockers 104 (78.2) 34 (81.0) 70 (76.9) 0.66
   Diuretics 23 (17.3) 6 (14.3) 17 (18.7) 0.63
   Lipid lowering therapy 65 (48.9) 20 (47.6) 45 (49.5) 0.85
Weekly peritoneal Kt/Vurea 1.4 ± 0.5 1.4 ± 0.3 1.4 ± 0.5 0.10
RKF (mL/min/1.73m2) 2.1 (0.1-5.5) 0.5 (0.1-5.0) 2.5 (0.1-5.8) 0.21
Urine volume (L/d) 0.50 (0.05-1.10) 0.20 (0.03-0.94) 0.60 (0.03-0.10) 0.27
GNRI 96.2 ± 8.3 96.2 ± 7.3 96.2 ± 8.7 0.9
Values are presented as mean ± standard deviation, number of patients (percentage), or median (interquartile range).
BUN, blood urea nitrogen; CAD, coronary artery disease; CHF, congestive heart failure; CVA, cerebrovascular accident; CVD, cardiovascular disease; GNRI, geriatric 
nutritional risk index; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; iPTH, intact parathyroid hormone; LDL-C, low-density lipo-
protein cholesterol; MACCE, major adverse cardiac and cerebrovascular events; PAD, peripheral artery disease; RAS, renin-angiotensin system; RKF, residual kidney 
function; SBP, systolic blood pressure.
*CVD: Composite of CAD, PAD, CVA, and CHF.
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Worsening or stationary GNRI one year after PD initiation 
as an independent risk factor for MACCEs
The mean GNRI value at one year after PD initiation 
was 94.9 ± 7.0 (median 94.0, IQR 90.8-99.8). When pa-
tients were dichotomized according to the median value 
of follow up GNRI, Kaplan-Meier analysis demonstrated 
that event-free survival rates were significantly lower 
in the lower GNRI group than in the higher group (log-
rank test, P = 0.03). To evaluate the prognostic value of 
GNRI changes, the delta GNRI was calculated from GNRI 
values at baseline and one year after PD initiation. Pa-
tients were classified according to baseline GNRI values 
and changes in GNRI value (Table 2). According to delta 
GNRI, patients were categorized into improved (delta 
GNRI > 0) and worsening or stationary (delta GNRI ≤ 0) 
groups. Fifty-two patients were in the improved GNRI 
group, and 81 patients were in the worsening or station-
ary GNRI group. Forty-eight patients (76.2%) exhibited 
worsening or stationary GNRI in the lower baseline GNRI 
group, while 33 patients (47.1%) exhibited worsening or 
stationary GNRI in the higher baseline GNRI group. The 
cumulative event-free survival rate was significantly low-
er in the worsening or stationary GNRI group (log-rank 
test, P = 0.004) than in the improved GNRI group (Fig. 2). 
Multivariate Cox analysis showed that worsening or sta-
tionary GNRI was an independent predictor of MACCEs 
(HR, 2.47; 95% CI, 1.15-5.29; P = 0.02) (Table 3). 
In addition, to investigate whether the impact of chan-
ges in GNRI on MACCE risk was affected by baseline 
nutritional status, subgroup analyses were performed ac-
cording to baseline GNRI group. Kaplan-Meier analysis 
revealed that the worsening or stationary GNRI group 
was at greater risk for MACCEs in both the lower and 
higher baseline GNRI groups (log-rank test, P = 0.04 
and P = 0.01, respectively) (Fig. 3). Multivariate Cox re-
gression analysis showed that worsening or stationary 
GNRI was independently associated with a higher risk of 
MACCEs (HR, 3.90; 95% CI, 1.45-10.53; P = 0.01) in pa-
tients with higher baseline GNRI values. In patients with 
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Figure 1. Kaplan-Meier analysis of baseline GNRI groups for 
MACCE. Baseline GNRI group was not significantly associated with 
incidence of MACCE (log-rank test, P = 0.40). 
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Figure 2. Kaplan-Meier analysis of GNRI change groups for 
MACCE. The worsening or stationary GNRI (delta GNRI ≤ 0) group 
showed significantly higher risk of MACCE compared to the improved 
GNRI (delta GNRI > 0) group (long-rank test, P = 0.004). 
GNRI, geriatric nutritional risk index; MACCE, major adverse cardiac 
and cerebrovascular event.
Table 2. Proportion of patients according to baseline GNRI value and GNRI changes during one year after PD initiation
Lower baseline GNRI group  
(GNRI < 96.7, n = 63)
Higher baseline GNRI group  
(GNRI ≥ 96.7, n = 70)
Improved GNRI group (delta GNRI > 0, n = 52) 15 (23.8) 37 (52.9)
Worsening or stationary group (delta GNRI ≤ 0, n = 81) 48 (76.2) 33 (47.1)
Values are presented as number of patients (percentage).
GNRI, geriatric nutritional risk index; PD, peritoneal dialysis.
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Figure 3. Kaplan-Meier analysis of GNRI change groups for MACCE according to baseline GNRI group. The worsening or stationary 
GNRI group had higher risk of MACCE compared to the improved group in both (A) lower and (B) higher baseline GNRI groups (log-rank test, P 
= 0.04 and 0.01, respectively).
GNRI, geriatric nutritional risk index; MACCE, major adverse cardiac and cerebrovascular event.
Table 3. Uni- and multivariate Cox regression analyses of GNRI change groups for MACCE
Variable
Unadjusted *Adjusted
HR (95% CI) P value HR (95% CI) P value
Age (yr) 1.05 (1.02-1.08) 0.001 1.06 (1.02-1.10) 0.002
Women (vs. men) 0.89 (0.48-1.63) 0.70 0.80 (0.42-1.52) 0.50
Diabetes mellitus 2.25 (1.01-5.01) 0.04 1.04 (0.41-2.49) 0.9
Cardiovascular disease 2.21 (1.08-4.54) 0.03 1.67 (0.76-3.66) 0.21
Ca × P (per mmol2/L2) 1.03 (0.98-1.03) 0.78 1.02 (0.99-1.05) 0.10
hs-CRP (per mg/L) 1.58 (0.80-3.11) 0.19 0.80 (0.45-1.44) 0.46
Urine volume (L/day) 0.99 (0.99-1.03) 0.39 1.00 (0.99-1.00) 0.38
GNRI change groups
   Improved group Reference Reference
   Worsening or stationary group 2.69 (1.34-5.39) 0.01 2.47 (1.15-5.29) 0.02
*Adjusted for age, sex, diabetes mellitus, history of cardiovascular disease, Ca × P products, hs-CRP, and residual urine volume.
Improved group included 52 patients with delta GNRI > 0; Worsening or stationary group included 81 patients with delta GNRI ≤ 0.
Ca, calcium; CI, confidence interval; GNRI, geriatric nutritional risk index; HR, hazard ratio; hs-CRP, high-sensitivity C-reactive protein; MACCE, major adverse cardiac 
and cerebrovascular events; P, phosphorus.
Table 4. Multivariate Cox regression analysis of GNRI change groups for MACCE according to baseline nutritional status
Unadjusted *Adjusted
HR (95% CI) P value HR (95% CI) P value
Lower baseline GNRI group (n = 63)
   Improved group Reference Reference
   Worsening or stationary group 3.46 (0.98-12.37) 0.06 3.33 (0.90-12.31) 0.06
Higher baseline GNRI group (n = 70)
   Improved group Reference Reference
   Worsening or stationary group 2.98 (1.25-7.11) 0.01 3.90 (1.45-10.53) 0.01
*Adjusted for age, sex, presence of diabetes mellitus, previous cardiovascular disease, and high sensitivity C-reactive protein.
Improved group included patients with delta GNRI > 0; Worsening or stationary group included patients with delta GNRI ≤ 0.
CI, confidence interval; GNRI, geriatric nutritional risk index; HR, hazard ratio; MACCE, major adverse cardiac and cerebrovascular events.
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higher in the worsening or stationary GNRI group than in 
the improved group, but the difference was not statistically 
significant (HR, 3.33; 95% CI, 0.90-12.31; P = 0.06) (Table 4).
Discussion
In the current study, we investigated the prognostic val-
ue of changes in GNRI during the first year of dialysis in 
determining MACCE risk for incident PD patients. Base-
line GNRI was not significantly associated with MACCEs. 
However, patients with worsened or unchanged GNRI 
value were at 2.47-fold greater risk for MACCEs than 
those with improved GNRI values. Moreover, the in-
creased MACCE risk in the worsening or stationary group 
was significant, irrespective of the baseline GNRI group. 
These findings suggest that regular assessment of nutri-
tional status using the GNRI could be useful for stratify-
ing cardiovascular risk in incident PD patients.
Protein-energy wasting is a well-known risk factor for 
cardiovascular disease and unfavorable clinical out-
comes, including mortality and impaired quality of life, 
in patients with ESRD treated with dialysis [2-8]. A num-
ber of studies have evaluated protein-energy wasting and 
its prognostic impact. The GNRI was developed primarily 
for elderly patients [16], and Yamada et al [13] first inves-
tigated the usefulness of GNRI as a nutritional indicator 
in patients on chronic HD. When malnutrition was de-
fined as malnutrition-inflammation score (MIS) ≥ 6, the 
area under the receiver operating characteristic curve 
(AUC) of the GNRI was larger than that of four other nu-
tritional indices—the mini nutritional assessment-short 
form (MNA-SF), nutritional risk score (NRS), malnutri-
tion universal screening tool (MUST), and malnutrition 
screening tool (MST) [13]. Similarly, GNRI and change in 
GNRI correlated significantly with MIS, a 7-point subjec-
tive global assessment (SGA), and their changes in PD 
patients [17]. In terms of clinical outcomes, the GNRI 
was found to significantly predict all-cause mortality in 
several HD studies [18,19,22] and PD [24] patients. The 
GNRI also predicted cardiovascular mortality in HD pa-
tients [22]. However, to date, there have been few stud-
ies investigating the effects of GNRI changes on clinical 
outcomes in patients with ESRD [20]. In a study of 75 HD 
patients, the GNRI, MIS, dietary energy intake, and body 
composition were measured at baseline and at 6, 12, and 
18 months after enrollment. The GNRI and MIS correlat-
ed with changes in nutritional biomarkers, inflammatory 
cytokine (interleukin-6) levels, and body composition 
parameters [20]. Moreover, both GNRI and MIS were sig-
nificantly associated with hospitalization, but only MIS 
was associated with mortality. 
In the present study, baseline GNRI at PD initiation was 
not significantly associated with MACCEs, but changes 
in GNRI over one year did affect the incidence of MAC-
CEs. Patients with worsening or stationary GNRI values 
were at greater risk for MACCEs than those with im-
proved GNRI values. In contrast, a study of 486 Korean 
PD patients indicated that the lowest tertile of baseline 
GNRI was significantly associated with higher all-cause 
mortality compared to the middle or higher tertiles [24]. 
Although we cannot clarify the reason for conflicting 
findings, differences in study outcomes and subjects are 
possible explanations. Compared with a previous study, 
the incidence of the study outcome was lower in our 
study (all-cause mortality, 50.8% vs. MACCE, 31.6%). Be-
cause we only included patients who maintained PD for 
at least one year, we may have underestimated the effect 
of baseline GNRI on study outcome. Other previous stud-
ies also showed that low baseline GNRI was a significant 
predictor of adverse outcomes in patients with ESRD 
[18,19,21-23]. Although the exact reason is unclear, we 
presume that differences in dialysis modality (HD or PD), 
dialysis vintage (prevalent or incident dialysis patients), 
study outcomes (all-cause mortality, cardiovascular mor-
tality, or cardiovascular events), and study design (retro-
spective or prospective) contributed to the discrepancies 
between our findings and previous findings. Because 
this study included only incident dialysis patients, the 
prognostic impact of changes in nutritional status can 
be more prominent in such patients than in patients on 
chronic dialysis. Furthermore, a previous study by our 
group demonstrated that changes in nutritional status as 
assessed by the SGA, not baseline nutritional status, were 
significantly associated with all-cause mortality in inci-
dent dialysis patients in a nationwide prospective cohort 
[15], supporting the results of the present study.
Although we did not completely elucidate the mecha-
nisms by which changes in GNRI are associated with 
MACCEs, the associations of nutritional status with 
inflammation and physical activity are possible expla-
nations. In patients with ESRD, protein-energy wasting 
is associated with inflammation and atherosclerosis, 
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suggesting that malnutrition can increase the risk of car-
diovascular mortality in these patients [3]. In our study, 
a significantly greater increase in hs-CRP concentration 
between baseline and one year after PD initiation was 
observed in the worsening or stationary GNRI group 
compared to the improved group (log delta hs-CRP, 
worsening or stationary group vs. improved group: 0.1 ± 
3.3 vs. -1.4 ± 2.4 mg/L; P = 0.03). Based on these results, 
progression of inflammation accompanied by a worsen-
ing nutritional status can explain the higher incidence 
of MACCEs in the worsening or stationary GNRI group. 
The significant association between nutritional status 
and physical activity is another possible explanation for 
our findings. In 48 prevalent PD patients, a low GNRI was 
associated with reduced physical activity, assessed by 
the daily number of steps and daily energy expenditure 
for 9 days [26]. Given that malnutrition and low physical 
activity are independent predictors of hospitalization, 
morbidity, and mortality in patients with ESRD [27,28], 
reduced physical activity might have contributed to the 
increased MACCE risk in patients in the worsening or 
stationary GNRI group. Unfortunately, we did not mea-
sure physical activity indices such as the number of daily 
steps or gait speed in our study. A comprehensive study 
with nutritional parameters and physical activity indices 
could be helpful to verify the association of nutritional 
status and physical activity with cardiovascular disease in 
patients with ESRD.
This study has several limitations. First, it included a 
small number of subjects. Because the stationary group 
was too small to analyze separately, we could not clarify 
the independent effect of stationary GNRI on the primary 
outcome. Although Kaplan-Meier analysis demonstrated 
that the risk of MACCEs was significantly elevated in the 
worsening or stationary GNRI group in both lower and 
higher baseline GNRI groups, the HR in the lower base-
line GNRI subgroup did not reach statistical significance 
in multivariate Cox regression analysis. Because there 
were very few improved patients in the lower baseline 
GNRI group (n = 15) and only three patients demon-
strated the primary outcome, the negative results of 
Cox regression analysis might have been due to lack of 
statistical power. Furthermore, sensitivity analysis was 
not performed according to various subgroups, such as 
diabetes mellitus. Thus, a future large-scale prospective 
investigation should be conducted to confirm our results. 
Second, only patients who maintained PD for over one 
year and had one-year follow-up data were included, 
resulting in selection bias. In particular, 73 patients who 
maintained PD for over one year but did not have follow-
up data were excluded. To mitigate the effect of selection 
bias, we first analyzed the difference in baseline char-
acteristics between the 133 included patients and 73 ex-
cluded patients. There were no significant differences in 
baseline characteristics between the two groups except 
for hs-CRP (Supplementary table 1). In addition, survival 
analysis for the prognostic value of baseline GNRI was 
performed in 206 patients including the 73 excluded pa-
tients. Kaplan-Meier analysis demonstrated that there 
was no significant difference in MACCE-free survival 
rates between the higher and lower baseline GNRI groups 
(log-rank test, P = 0.9), in accordance with the primary 
result (Supplementary fig. 1). Nevertheless, 133 patients 
might not be representative of all incident PD patients, 
leading to potential selection bias. Third, only GNRI 
was used as a nutritional indicator. However, when the 
GNRI was compared with other nutritional indices, the 
AUC of the GNRI was the largest, suggesting that GNRI is 
superior for identifying nutritional risk in patients with 
ESRD [13]. Along with GNRI, the SGA and MIS are also 
validated nutritional assessment tools in dialysis patients 
[9-12,15], but both the SGA and MIS are based on sub-
jective assessment. Therefore, these methods require a 
skilled examiner and are prone to inter-observer variabil-
ity. In contrast, the GNRI is calculated from three objec-
tive variables: height, body weight, and serum albumin 
concentration. Taken together, these findings indicate 
that the GNRI is a simple nutritional assessment method 
and is suitable for large-scale population-based research. 
Fourth, there is no definite GNRI cutoff value for malnu-
trition in PD patients. We dichotomized patients by the 
median value of the GNRI (96.7). This value was similar 
to that previously reported for Korean PD patients [24]. In 
486 PD patients, the cutoff value for time-averaged GNRI 
over one year for a diagnosis of a decline in lean mass 
was 96.4 [24]. In addition, when we tested different cutoff 
values, our results did not change. Baseline GNRI was 
not significantly associated with MACCEs when we used 
a cutoff value of 90 (log-rank test, P = 0.16) [18] or 92 (P = 
0.36) [23]. Fifth, we determined the GNRI only two times 
per patient—at PD initiation and after one year. There are 
no definite guidelines for the frequency of nutritional as-
Lee, et al. GNRI changes and MACCE in PD
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sessment; however, a 4- to 6-month interval is suggested 
for patients with stable ESRD [15]. Studies with more 
frequent follow-up over a longer period of time would 
be worthwhile. Finally, because this was a retrospective 
study, residual confounding effects of other risk factors 
such as previous history of cardiovascular disease cannot 
be totally excluded and could not provide evidence for 
intervention to reduce the risk of MACCEs.
In conclusion, the current study demonstrated that 
there was no association between baseline GNRI and 
MACCEs. However, incident PD patients whose nutri-
tional status deteriorated or remained unchanged were at 
significantly greater risk for MACCEs than patients whose 
nutritional status improved. These findings suggest that 
serial monitoring of nutritional status is important to 
stratify cardiovascular risk in incident PD patients.
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